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1. Introduction 2. Materials and methods 
An inbred strain of rat (gsd/gsd) with a glycogen 
storage disease has been described in [1]. The defect 
in these animals appears to result from a deficiency of 
liver phosphorylase kinase [2]. Besides exhibiting mild 
hypoglycaemia in the fed state and inability to mobilise 
glycogen in the fasted state, these animals how ab- 
normalities in lipid metabolism in that they have 
diminished rates of hepatic fatty acid and cholesterol 
synthesis and considerably ower concentrations of
plasma triacylglycerols [3]. It is apparent that these 
animals may be a useful model for studies of equiva- 
lent forms of human glycogen storage diseases and it 
was therefore of interest o investigate some enzy- 
matic aspects of lipid metabolism in this condition. 
Accordingly measurements have been made of hepatic 
glycerolphosphate acyltransferase (GPAT) activities 
(mitochondrial nd microsomal) and dihydroxyace- 
tonephosphate acyltransferase (DHAPAT) activity. 
These activities have been found to change in a num- 
ber of physiological states and change in parallel with 
changes in hepatic triacylglycerol synthesis and secre- 
tion [4-7]. The activity of the overt form of carnitine 
pahnitoyltransferase (CPT1) has also been measured 
in liver mitochondria and the sensitivity of this 
enzyme to inhibition by malonyl CoA determined. 
This is thought o be an important factor in the regu- 
lation of hepatic fatty acid oxidation [8] and the sen- 
sitivity to this effector has been shown to change in 
at least one physiological state, namely fasting [9]. 
* Permanent address: Department ofBiochemistry, University 
College London, Gower Street, London, WC1E 6BT, 
England 
Coenzyme A thioesters were from PL-Biochemicals, 
L-carnitine from Sigma, radiochemicals from The 
Radiochemical Centre (Amersham) and other chemi- 
cals from Boehringer (Mannheim). 
Adult male gsd/gsd (GSD(+)) and control (GSD(-)) 
rats, a substrain of the NZR/Gd line [ 1] were used. 
These were fed a standard iet with water ad libitum. 
The animals were anaestlietised with dietliyl ether at 
10:00-11:00 h and a 1-2 g portion of liver freeze- 
clamped in situ between metal blocks previously 
cooled in liquid nitrogen. Freeze-clamped pieces of 
liver were stored at -80°C. Portions of these were 
subsequent!y pulverised under liquid nitrogen in a 
mortar, transferred to a glass Potter-Elvejhem homog- 
eniser and vigorously liomogenised (25 strokes) with 
a motor-driven teflon pestle in an ice-cold sucrose 
medium consisting of 0.23 M sucrose, 10 mM Tris-- 
HC1 (pH 7.4), 10 mM KF, 1 mM EDTA, 1 mM EGTA 
and 0.25 mM dithiothreitol (60 mg liver/ml medium). 
The resulting homogenate was used directly for assay 
of GPAT and DHAPAT. A further 3 -4  g portion of 
liver was removed from the animal and homogenised 
(4 strokes) in the same ice-cold sucrose medium and 
centrifuged to obtain mitochondria as in [10]. The 
mitochondria were washed with this buffer and finally 
resuspended in the same buffer at ~4 mg mitochondrial 
protein/ml. Protein was measured [ 11 ] using bovine 
serum "albumin as a standard. 
Aliquots (50 #1) of fresh whole mitochondria were 
assayed for CPT (EC 2.3.1.21) activity at 25°C in 
1.0 ml containing 200 ~tM L-[3H]carnitine, 40/JM 
palmitoyl CoA and defatted albumin (1.3 mg/ml) as 
in [9]. Aliquots (50 ~1) of homogenised frozen liver 
were assayed at 30°C for GPAT (EC 2.3.1.15) and 
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Table 1 
GPAT activities in GSD(+) and GSD(-) rat livers 
September 1981 
Patmitoyl CoA Palmitoyl CoA Palmitoyl CoA Oleoyl CoA 
(total activity) (NEM-insensitive activity) (NEM-sensitive activity) (total activity) 
GSD(-) 
nmol .min - l .gwetwt  -1 201_ + 23 102+- 11 99+- 12 120- + 8 
nmol. rain -1 . liver -1 2858 -+ 246 1454 -+ 136 1405 +- 126 1705 +- 61 
GSD(+) 
nmol. rain -~ . g wet wt -~ 144 +- 5 a 67 +- 4 a 77 _+ 1 100 +- 2 
nmol. rain -~. liver -~ 2250 _+ 51 a 1046 +- 17 a 1204 +- 54 1561 +- 69 
a Indicates P < 0.05 for GSD(+) vs GSD(-) 
The activities are means -+ SEM of 4 animals in each case. Assays were performed with palmitoyl CoA or oleoyl CoA as acyl sub- 
strate as indicated. Where present NEM was 10 mM 
DHAPAT (EC 2.3.1.42) using the conditions in [6]. 
The GPAT assay contained 45/aM palmitoyl CoA or 
oleoyl CoA and 0.5 mM [U-14C]glycerol phosphate. 
The DHAPAT assay contained 60 #M palmitoyl CoA 
and 0.5 mM [U-14C] dihydroxyacetonephosphate 
(generated in situ from fructose bisphosphate [6]). 
Both assays contained efatted albumin (4 mg/ml). 
Results are expressed as means -+ SEM and statis- 
tical significance determined using Student's t-test. 
3. Results and discussion 
The mean wet weights of livers were: GSD(+) rats, 
15.7 -+ 0.8 g; GSD( - )  rats, 14.4 -+ 0.6 g (4 animals in 
each case). GPAT in microsomes differs from the activ- 
ity in mitochondria in that the former is inhibited by 
thiol reagents whereas the latter is insensitive [ 12-14] .  
This difference may be exploited to obtain estimates 
of mitochondrial  and microsomal GPAT activities in 
crude homogenates of freeze-clamped tissue without 
recourse to subcellular f actionation [6]. Accordingly, 
GPAT that is insensitive to 10 mM N-ethylmaleimide 
(NEM) refers to the mitochondrial  form and the 
NEM-sensitive activity, calculated by difference, refers 
to the microsomal form [6]. An alternative stimate 
of microsomal GPAT is obtained by using an unsatu- 
rated acyl substrate, i.e., oleoyl CoA since fiver mito- 
chondrial GPAT has tittle activity with this substrate 
[13] and >95% of total homogenate GPAT activity 
with oleoyl CoA is NEM-sensitive [15]. Both forms 
of estimation are employed here (table 1). 
Livers from GSD(+) rats had reduced GPAT activ- 
ities (table 1). This was mainly due to a significant 
decrease in the NEM-insensitive activity rather than a 
change in the microsomal activity. It is noteworthy 
that in various other states, alterations in hepatic GPAT, 
that parallel changes in hepatic triacylglycerol synthesis 
are mainly confined to the mitochondrial  form of the 
enzyme [4-6] .  In the GSD(+) state there was also a 
significant decrease in the total hepatic DHAPAT 
activity (table 2). In percentage terms this was similar 
to the decrease in the mitochondrial  GPAT (table 1). 
NEM stimulates DHAPAT in peroxisomal and mito- 
chondrial fractions [6,16], but decreases that in 
microsomal fractions [6,17]. Assays performed in the 
presence of NEM should therefore stimate an activity 
Table 2 
DHAPAT activities in GSD(+) and GSD(-) rat livers 
Assayed with- Assayed with 
out NEM NEM (10 mM) 
GSD(-) 
nmol .min-~.gwetwt -~ 37.5 + - 1.2 37.7+ 2.1 
nmol. min -~.liver -~ 537 +- 15 540 _+ 25 
GSD(+) 
nmol. rain -~. g wet wt -1 23.9 +- 0.1 b 25.9 +- 1.1 a 
nmol. min -~.liver -~ 375 +- 19 b 404 +- 13 a 
a,b Indicate P < 0.01, < 0.001 for GSD(+) vs  GSD(-) 
The activities are means +- SEM of 4 animals in each case 
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Fig.l. Effects ofmalonylCoA on CPT 1 activity. The activities 
are means -+ SEM of 3 expt and are expressed as percentages 
of the CPT 1 activity in the absence of malonyl CoA: (o) 
GSD(-); (o) GSD(+). CPT 1 activities in the absence of 
malonyl CoA were: GSD(+), 2.25 -+ 0.09; GSD(-), 1.86 + 
0.04 (nmol. min -1 . mg protein-I; n = 4; P < 0.01). Total 
CPT activities in the presence of Triton X-100 (0.4 mg/ml) 
were: GSD(+) 5.19 + 0.11; GSD(-) 4.31 -+ 0.08 (nmol. 
min -~ . mg protein-I; n = 4;P < 0.001). 
in which the contribution from a microsomal enzyme 
is small. Since a diminished DHAPAT activity was also 
seen in the GSD(+) livers in the presence of NEM, it is 
likely that it is non-microsomal DHAPAT activity 
which is decreased in this condition. 
The mechanisms underlying the observed ecreases 
in GPAT and DHAPAT activities are unknown at 
present. However, the freeze-stop and rapid assay 
techniques employed are likely to detect changes 
resulting both from covalent modification of activity 
as well as more persistant alterations in total enzyme 
protein. 
Figure 1 shows that the sensitivity of CPT1 to 
malonyl CoA inhibition was unaltered in the GSD(+) 
state with a mean concentration of malonyl CoA for 
50% inhibition of ~4/aM. However, the activities of 
both CPT1 (expressed per mg mitochondrial protein) 
and total CPT activity measured after disruption of 
mitochondria with Triton X-100 were increased by 
20% (see legend to fig.l). These changes, and those 
in GPAT and DHAPAT, presumably reflect the initial 
lesion in glycogen metabolism. It has not yet been 
established whether the lowering of plasma triacyl- 
glycerols in the GSD(+) state [3] is due to a decrease 
in hepatic triacylglycerol synthesis. However, the 
increases in CPT and the diminished activities of 
DHAPAT and NEM-insensitive GPAT would tend to 
redirect hepatic fatty acid metabolism away from 
esterification and towards oxidation and also depress 
triacylglycerol secretion. 
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